This activity is expired and is no longer available for CME credit.


Diabetic Retinopathy: Assessing the Armamentarium for Improved Detection and Treatment

Author(s)/Faculty: Andrew A. Moshfeghi, MD, MBA; Carl D. Regillo, MD, FACS; Nathan C. Steinle, MD
Release Date: 4/12/2019Expiration Date: 4/11/2020
Credit Type: CMENumber of Credits: 0
Content Type: LectureProvider:
Anti-VEGF therapy is an important addition to the treatment options for diabetic retinopathy (DR) and is the only medical option that has been granted US Food and Drug Administration approval. Most ophthalmologists are reluctant to use this therapy and, instead, continue employing laser photocoagulation. Additionally, imaging options such as ultra-widefield photography and Optical Coherence Tomography angiography remain underused, presumably because clinicians have not yet adopted new treatment options that would benefit patient outcomes through early detection. This CME activity will describe how to utilize imaging techniques that aid in the early diagnosis, assessment, and monitoring of DR as well as the efficacy of anti-VEGF therapy in patients with DR.